| Mar 12, 2014
Re "Prices of new drugs tough to take," March 10
I understand the necessity for drug companies to recoup research and development costs. But in regard to a medication that can cure hepatitis C, a spokesman for the maker of one drug that costs about $1,...
| Feb 6, 2014
| 3:45 PM
WASHINGTON – The United States could be losing its edge in science and technology as emerging nations rapidly increase their investment in research and development, according to new indicators released Thursday by the National Science Board....
| Jan 27, 2014
| 1:05 PM
WASHINGTON – The interim nuclear deal between Iran and world powers will allow Tehran to continue far more research and development on centrifuges to enrich uranium than has been publicly recognized, according to a veteran Washington nuclear...
| May 27, 2014
| 11:07 AM
A day before would-be buyer Valeant Pharmaceuticals is set to unveil a second, unsolicited takeover bid, its acquisition target, Allergan Inc., sought to discredit the company by filing a presentation with regulators questioning the viability of Valeant's...
| May 27, 2014
| 6:33 PM
The billion-dollar takeover battle targeting Irvine-based Allergan is heading into high gear this week with both sides on the attack.
On Tuesday, Allergan Inc., the maker of Botox, launched a broadside against Canadian rival Valeant Pharmaceutics...
| May 28, 2014
| 5:37 PM
For weeks, Valeant Pharmaceuticals had promised a better offer for Botox maker Allergan, but its renewed cash-and-stock offer fell flat with investors and analysts.
After Irvine-based Allergan Inc. rejected a $46-billion offer earlier this month, the...
| May 16, 2014
| 8:05 AM
Gov. Martin O'Malley signed a bill Thursday creating a regional 3D printing and additive manufacturing authority in collaboration with the Edgewood Chemical Biological Center at Aberdeen Proving Ground.
The bill, creating the Northeast Maryland Additive...
| May 18, 2014
Research labs closed by pharmaceutical giant Pfizer dot the country: Illinois. Michigan. New Jersey. New York. North Carolina.
Maryland officials don't want this state to join that list.
After Pfizer declared its desire to buy AstraZeneca — which...
| May 20, 2014
| 3:00 AM
Athletes associate STX with lacrosse, but the Baltimore-based brand began appearing last month in stores on ice hockey sticks and plans to launch a line of men's field hockey sticks in the United Kingdom.
For the 44-year-old inventor of the modern...
| Dec 18, 2013
| 11:55 AM
Followers of Herbalife, the Los Angeles peddler of nutritional supplements, know it's actually two stories rolled into one.
One is the story of how a company with a questionable business model, overhyped products, and an almost invisible research and...
| May 6, 2014
| 6:57 PM
The board and chief executive of Irvine takeover target Allergan Inc. heard a voice from the past Tuesday at the company's annual meeting of shareholders.
Gavin S. Herbert, Allergan's co-founder and former chairman, urged the company's directors to...